Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “OSTEOSARCOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00642941
What this trial is testing

R1507 in Participants With Recurrent or Refractory Sarcoma

Who this might be right for
Sarcoma
Hoffmann-La Roche 317
Testing effectiveness (Phase 2)Study completedNCT01987102
What this trial is testing

Investigation of [6R] 5,10-methylenetetrahydrofolate (Arfolitixorin) as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX.

Who this might be right for
Osteosarcoma
Isofol Medical AB 18
Testing effectiveness (Phase 2)Study completedNCT00889057
What this trial is testing

Sorafenib in Relapsed High Grade Osteosarcoma

Who this might be right for
Osteosarcoma
Italian Sarcoma Group 35
Testing effectiveness (Phase 2)Study completedNCT00041236
What this trial is testing

Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 39
Not applicableStudy completedNCT05093101
What this trial is testing

The Prognostic Value of Serum Biomarkers in Osteosarcoma

Who this might be right for
Osteosarcoma
Istituto Ortopedico Rizzoli 600
Early research (Phase 1)Study completedNCT00020267
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Lung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213652
What this trial is testing

Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmMalignant Solid NeoplasmRecurrent Ependymoma+30 more
National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07820033
What this trial is testing

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial

Who this might be right for
Advanced CancerStage IV Solid Tumor CancerStage IV Sarcoma of Bone+3 more
University Health Network, Toronto 46
Testing effectiveness (Phase 2)Study completedNCT03220035
What this trial is testing

Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 4
Not applicableNot Yet RecruitingNCT06927596
What this trial is testing

A Look Back at How Well Interventional Treatments Work for Bronchopleural Fistulas in Patients With Lung Metastases From Osteosarcoma

Who this might be right for
Osteosarcoma Metastatic
Ruijin Hospital 28
Early research (Phase 1)WithdrawnNCT02557854
What this trial is testing

HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors

Who this might be right for
RhabdomyosarcomaNeuroblastomaSarcoma+3 more
Theodore Laetsch
Testing effectiveness (Phase 2)Ended earlyNCT02624388
What this trial is testing

Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)

Who this might be right for
LymphomaChildhood LymphomaSolid Tumor+13 more
University of Virginia 4
Not applicableEnded earlyNCT01882231
What this trial is testing

Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma

Who this might be right for
OsteosarcomaPaget's DiseaseEwing Sarcoma
Vanderbilt-Ingram Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00586846
What this trial is testing

Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma

Who this might be right for
Osteosarcoma
Memorial Sloan Kettering Cancer Center 40
Early research (Phase 1)Ended earlyNCT01491594
What this trial is testing

Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia

Who this might be right for
Sarcoma, Soft TissueOsteosarcomaNeoplasms, Connective and Soft Tissue
Duke University 1
Testing effectiveness (Phase 2)UnknownNCT06217003
What this trial is testing

Trilaciclib Combined With Chemotherapy for Perioperative Treatment of Osteosarcoma

Who this might be right for
Osteosarcoma
The First Affiliated Hospital of Xinxiang Medical College 20
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Ended earlyNCT00038142
What this trial is testing

Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients

Who this might be right for
Ewing's Sarcoma
M.D. Anderson Cancer Center 46
Early research (Phase 1)Looking for participantsNCT07297979
What this trial is testing

Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)

Who this might be right for
Ewing Sarcoma
Amgen 50
Testing effectiveness (Phase 2)Study completedNCT02304458
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas

Who this might be right for
Metastatic MelanomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 140
Next Page